Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rebecca Malloy"'
Autor:
Joe K. Taylor, Henry E. Revercomb, David C. Tobin, Robert O. Knuteson, Michelle L. Loveless, Rebecca Malloy, Lawrence Suwinski, Flavio Iturbide-Sanchez, Yong Chen, Glen White, Joe Predina, David G. Johnson
Publikováno v:
Remote Sensing, Vol 15, Iss 3, p 718 (2023)
The Cross-track Infrared Sounder (CrIS) is an infrared Fourier-transform spectrometer that measures the Earth’s infrared radiance at high spectral resolution and high accuracy. The potential for polarization errors contributing significantly to the
Externí odkaz:
https://doaj.org/article/6384f2ef15554ec3b39b47722dfd8e7d
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundProgression after high-dose melphalan with autologous stem cell transplantation (ASCT) in multiple myeloma (MM) may be due in part to immune dysfunction. Regulatory T (Treg) cells reconstitute rapidly after ASCT and inhibit immune responses
Externí odkaz:
https://doaj.org/article/2a71796b0469427e954363ddde265cbb
Autor:
Benjamin A. Derman, Yuanyuan Zha, Justin Kline, Andrzej Jakubowiak, Rebecca Malloy, Todd Zimmerman, Michael R. Bishop
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundProgression after high-dose melphalan with autologous stem cell transplantation (ASCT) in multiple myeloma (MM) may be due in part to immune dysfunction. Regulatory T (Treg) cells reconstitute rapidly after ASCT and inhibit immune responses
Autor:
Sadi Dixon, Mylove Mortel, Rebecca Malloy, Lucy A. Godley, Melissa Sheppard, Linda Schroeder, Mary Lappe, Emma Nunley, Michael R. Bishop, Satyajit Kosuri
Publikováno v:
Transplantation and Cellular Therapy. 27:S110
Autor:
Todd M. Zimmerman, Yuanyuan Zha, Michael R. Bishop, Justin Kline, Yolanda Barnes, Andrzej Jakubowiak, Rebecca Malloy, Benjamin A. Derman
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S405-S406
Introduction High dose melphalan with autologous stem cell transplantation (ASCT) is a therapy mainstay in multiple myeloma (MM). However, the median PFS after ASCT is under 5 years even with contemporary agents. This may be due to immune dysfunction
Autor:
Justin Kline, Andrzej Jakubowiak, Michael R. Bishop, Todd M. Zimmerman, Cara A. Rosenbaum, Koen van Besien, Rebecca Malloy, Amittha Wickrema, Gottfried von Keudell
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 14:S150-S152
Although autologous stem cell transplantation (ASCT) is effective for patients with multiple myeloma (MM), disease relapse remains problematic. Despite significant advances in therapeutics for MM, it remains mostly incurable. Following ASCT, a majori
Publikováno v:
Cancer. 83:1540-1545
BACKGROUND Paclitaxel, an effective chemotherapeutic agent in the management of breast carcinoma, may have activity in women whose disease has recurred after high dose chemotherapy. With this is mind the authors explored the addition of a 120-hour co
Publikováno v:
Biology of Blood and Marrow Transplantation. 18:S385